Adding Early Docetaxel to ADT for Metastatic Prostate Cancer Improves Survival (FREE)

By Kelly Young Edited by Susan Sadoughi, MD Adding early docetaxel to a regimen of androgen-deprivation therapy in patients with prostate cancer is …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news